Background: Local and systemic inflammation occur at the same time in asthma and high sensitive CRP may play a role in the pathogenesis of this disease. Conventional approaches to monitor and control asthma involve no direct assessment of airway inflammation. There are some recent data postulating a discrepancy between the markers of airway and systemic inflammation and asthma control test (ACT) scores. In this study we evaluate the correlation between the serum levels of hs-CRP in patients with different levels of asthma control based on ACT scores and spirometric indices.
INTRODUCTION
C-reactive protein is a sensitive marker of inflammation, infection, and tissue damage (1) . Its synthesis by the liver is regulated to a large extent by the proinflammatory cytokine interleukin (IL-6) (2). The rise in CRP is driven by its rate of synthesis and falls rapidly when the pathologic stimulus ceases (3) . High sensitivity assays for CRP (hs-CRP) have become available in clinical laboratories (4) . hs-CRP is a strong independent predictor of future myocardial infarction, stroke and peripheral arterial diseases and is a prognostic marker for the development of diabetes mellitus (5, 6) . Furthermore, it is increased in COPD in stable condition and during exacerbations (7) .
Asthma is a chronic inflammatory disease of the airways with multiple dimensions and phenotype expressions. In asthma, local and systemic inflammation occur and hs-CRP may play a role in its pathogenesis (8) .
Other studies have shown that increased level of hs-CRP is associated with respiratory symptoms in non-allergic asthmatic adults (9) and the serum level of hs-CRP during exacerbation is significantly higher than the serum level during remission (10) . There is a direct correlation between the serum levels of hs-CRP and severity of asthma (11) .
TANAFFOS
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Tanaffos 2013; 12 (3) : [44] [45] [46] [47] [48] Recent international guidelines indicate that the primary goal of asthma treatment is to obtain optimal control and reduce the risk of exacerbations (12) . There are several questionnaires that may be useful for assessing asthma control. In 2004 Nathan et al. developed Asthma Control Test (ACT) for the assessment of asthma control (13) . The ACT contains five items: the effect of asthma on daily activities, daytime and nocturnal symptoms, use of rescue medications and self assessment of asthma control.
Each question has a 5 point scale and the ACT score is the sum of the five scores (13, 14) . Pulmonary function assessment by spirometry is another simple and practical tool for assessing asthma control.
While achievement of asthma control and suppression of airway inflammation are considered as important goals, conventional approaches to monitor and control asthma involve no direct assessment of airway inflammation. A positive association was found between inflammatory markers and ACT scores in stable asthmatic patients (5, 15) but there are some recent data postulating a discrepancy between the markers of airway and systemic inflammation and ACT scores (16) (17) (18) (19) .
In this study, we evaluate the correlation between the serum levels of hs-CRP in patients with different levels of asthma control based on ACT scores and spirometric indices.
MATERIALS AND METHODS
This prospective, case-control study was performed According to GINA degrees of asthma control (21), asthma was controlled in 59% of patients, partly controlled in 30% and uncontrolled in 11%. There were no significant differences in hs-CRP levels between these three groups (P=0.81) ( Table 1 ). In addition, no significant correlation was found between hs-CRP and FEV1 (P=0.5, r= -0.68). The five ACT items were not significantly associated with hs-CRP levels; however, the correlation of hs-CRP with nocturnal symptoms was greater than other items.
DISCUSSION
The present study results showed no association between the clinical indices of asthma control and the hs-CRP levels in asthmatic patients.
Asthma is a heterogeneous complex inflammatory There are several published questionnaires that may be useful for assessing asthma control. The ACT questionnaire has been previously assessed by specialist consultaions (13) and has been validated in Persian language (20) . It has shown a good relationship with therapeutic decisions made by specialists (24) We could not find a correlation between hs-CRP and FEV1. This relationship has been evaluated in other studies. Takemura (4) showed an association between systemic inflammatory markers and decreased pulmonary function. Soferman (9), Fujita (10), Pinto-plata (26) and Al
Obaidi et al. (27) showed that serum levels of hs-CRP were inversely correlated with FEV1. On the other hand, other studies showed that PFT values might be within normal range when the inflammatory process of the airways is still ongoing and anti-inflammatory treatment is still indicated (9). Senna et al. (28) postulated that the degree of bronchial inflammation is more sensitively detected by FeNo than by values.
The rise in CRP is drive by its rate of synthesis, reaches a peak at around 48 hours and falls rapidly when the pathologic stimulus ceases (29) . The elevation levels of hs-CRP in well controlled patients suggests a theory that asthmatic patients could have subclinical inflammation that could subsequently cause problems. Even in asthmatic patients with controlled disease eosinophilic inflammation in the airways is still present (27) . A Cochrane review stated that a treatment strategy based on the sputum eosinophil reduction in contrast to a strategy using international guidelines, leads to a greater decrease in the overall risk of exacerbation (30) .
These results provide us with a strong argument to develop and institute therapies aimed at decreasing the inflammatory state in asthmatics not only based on clinical markers but also on systemic inflammatory markers.
In conclusion, we found no correlation between degree 
